Answers are grounded in this paper and cite their sources.
Clinical trials of topical glucocorticosteroids employ a variety of evaluating methods. This makes it difficult to assess the relative strengths of the products without resorting to direct comparative trials between them. We propose a standardized evaluation system for this class of pharmaceuticals that can easily be adopted by any competent dermatologist. Its use would facilitate evaluation of new topical glucocorticosteroids.
No takes yet. Share an insight, caveat, or question.
Fredriksson et al. (1983) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: